The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer

被引：94
|
作者：
Kapeleris, Joanna [1 ,2 ]
Kulasinghe, Arutha [1 ,2 ]
Warkiani, Majid E. [3 ,4 ]
Vela, Ian [5 ,6 ]
Kenny, Liz [7 ]
O' Byrne, Kenneth [1 ,2 ,8 ]
Punyadeera, Chamindie [1 ,2 ]
机构：
[1] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Biomed Sci, Kelvin Grove, Qld, Australia
[2] Translat Res Inst, Brisbane, Qld, Australia
[3] Univ Technol Sydney, Sch Biomed Engn, Sydney, NSW, Australia
[4] IM Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow, Russia
[5] Princess Alexandra Hosp, Dept Urol, Woolloongabba, Qld, Australia
[6] Queensland Univ Technol, Australian Prostate Canc Res Ctr, Inst Hlth & Biomed Innovat, Translat Res Inst,Princess Alexandra Hosp, Brisbane, Qld, Australia
[7] Univ Queensland, Royal Brisbane & Womens Hosp, Sch Med, Cent Integrated Reg Canc Serv,Queensland Hlth, Brisbane, Qld, Australia
[8] Princess Alexandra Hosp, Queensland Hlth, Brisbane, Qld, Australia
来源：
FRONTIERS IN ONCOLOGY | 2018年 / 8卷
关键词：
lung cancer; NSCLC; SCLC; Circulating tumor cells; liquid biopsy; PROGRESSION-FREE SURVIVAL; CLINICAL-SIGNIFICANCE; BREAST-CANCER; PERIPHERAL-BLOOD; MUTATIONAL ANALYSIS; MOLECULAR ANALYSIS; PROSTATE-CANCER; PULMONARY VEIN; CHEMOTHERAPY; EGFR;
D O I：
10.3389/fonc.2018.00311
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Lung cancer affects over 1.8 million people worldwide and is the leading cause of cancer related mortality globally. Currently, diagnosis of lung cancer involves a combination of imaging and invasive biopsies to confirm histopathology. Non-invasive diagnostic techniques under investigation include "liquid biopsies" through a simple blood draw to develop predictive and prognostic biomarkers. A better understanding of circulating tumor cell (CTC) dissemination mechanisms offers promising potential for the development of techniques to assist in the diagnosis of lung cancer. Enumeration and characterization of CTCs has the potential to act as a prognostic biomarker and to identify novel drug targets for a precision medicine approach to lung cancer care. This review will focus on the current status of CTCs and their potential diagnostic and prognostic utility in this setting.
引用
收藏
页数：13
相关论文
共 50 条
  • [31] Detection of circulating tumor cells (CTCs) is a prognostic factor in first-line metastatic breast cancer (MBC)
    Cristofanilli, M
    Reuben, JM
    Fritsche, HA
    Hayes, DF
    Budd, TG
    Ellis, MJ
    Stopeck, A
    Miller, CM
    Matera, J
    Allard, JW
    Terstappen, LWMM
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S225 - S225
  • [32] Circulating tumor cells (CTCs) - clinical significance in patients with ovarian cancer
    Magnowski, Piotr
    Bochynski, Hubert
    Nowak-Markwitz, Ewa
    Zabel, Maciej
    Spaczynski, Marek
    GINEKOLOGIA POLSKA, 2012, 83 (04) : 291 - 294
  • [33] Effect of circulating tumor cells (CTCs) on metastatic progression in colorectal cancer
    Gevorkyan, Yuri
    Kit, Oleg Ivanovich
    Novikova, Inna Arnoldovna
    Soldatkina, Natalya
    Bakhtin, Andrey Vladimirovich
    Shulikov, Pavel B.
    Milakin, Anton G.
    Kolesnikov, Vladimir
    Ilchenko, Sergei A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Circulating tumor cells in lung cancer
    Bordi, Paola
    Tiseo, Marcello
    LUNG CANCER MANAGEMENT, 2012, 1 (02) : 105 - 112
  • [35] The Mechanical Fingerprint of Circulating Tumor Cells (CTCs) in Breast Cancer Patients
    Nel, Ivonne
    Morawetz, Erik W.
    Tschodu, Dimitrij
    Kas, Josef A.
    Aktas, Bahriye
    CANCERS, 2021, 13 (05) : 1 - 19
  • [36] Prognostic value of baseline circulating tumor cells (CTCs) enumerations is for stage III and stage IV breast cancer
    Zhang, Qiang
    Cai, Zheng
    Gerratana, Lorenzo
    D'Amico, Paolo
    Davis, Andrew A.
    Jacob, Saya Liz
    Vagia, Elena
    Shah, Ami N.
    Flaum, Lisa
    Zhang, Youbin
    Qiang, Wenan
    Wehbe, Firas
    Behdad, Amir
    Gradishar, William
    Platanias, Leonidas C.
    Cristofanilli, Massimo
    CANCER RESEARCH, 2021, 81 (04)
  • [37] Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)
    Hall, C.
    Hess, R.
    Ravenberg, L.
    Clayborn, A.
    Rauch, G. M.
    Candelaria, R.
    Mittendorf, E. A.
    Moulder, S. L.
    Thompson, A.
    Lucci, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [38] Circulating tumor cells as a prognostic factor in patients with small cell lung cancer
    Igawa, Satoshi
    Gohda, Keigo
    Fukui, Tomoya
    Ryuge, Shinichiro
    Otani, Sakiko
    Masago, Akinori
    Sato, Jun
    Murakami, Katsuhiro
    Maki, Sachiyo
    Katono, Ken
    Takakura, Akira
    Sasaki, Jiichiro
    Satoh, Yukitoshi
    Masuda, Noriyuki
    ONCOLOGY LETTERS, 2014, 7 (05) : 1469 - 1473
  • [39] Circulating Tumor Cells in Lung Cancer
    Young, Rachel
    Pailler, Emma
    Billiot, Fanny
    Drusch, Francoise
    Barthelemy, Amelie
    Oulhen, Marianne
    Besse, Benjamin
    Soria, Jean-Charles
    Farace, Francoise
    Vielh, Philippe
    ACTA CYTOLOGICA, 2012, 56 (06) : 655 - 660
  • [40] Meta-analysis of Circulating Tumor Cells as a Prognostic Marker in Lung Cancer
    Ma, Xue-Lei
    Xiao, Zhi-Lan
    Liu, Lei
    Liu, Xiao-Xiao
    Nie, Wen
    Li, Ping
    Chen, Nian-Yong
    Wei, Yu-Quan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (04) : 1137 - 1144
12345